Low MBOAT7 expression, a genetic risk for MASH, promotes a profibrotic pathway involving hepatocyte TAZ upregulation.
Moore MP, Wang X, Kennelly JP, Shi H, Ishino Y, Kano K, Aoki J, Cherubini A, Ronzoni L, Guo X, Chalasani NP, Khalid S, Saleheen D, Mitsche MA, Rotter JI, Yates KP, Valenti L, Kono N, Tontonoz P, Tabas I.
Moore MP, et al. Among authors: aoki j.
Hepatology. 2025 Feb 1;81(2):576-590. doi: 10.1097/HEP.0000000000000933. Epub 2024 May 22.
Hepatology. 2025.
PMID: 38776184